West Pharmaceutical Services Inc

Healthcare · Medical Instruments & Supplies

365.00$ -1.6% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Balance Sheet

West Pharmaceutical Services Inc (WST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 4,270 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet WST
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	477	478	506	552	557	511	537	624	659	824	918	1,186	1,169	1,271	1,294	1,399	1,564	1,672	1,671	1,695	1,717	1,863	1,592	2,341	2,794	3,314	3,617	3,830	3,643	4,270
Current Assets	157	171	160	185	173	159	161	217	227	237	282	412	366	397	437	472	557	651	659	674	642	744	894	1,059	1,374	1,742	1,920	1,936	1,538	1,978
Cash	27	52	31	45	43	42	33	38	69	49	47	108	87	83	110	92	162	230	255	275	203	236	337	439	616	763	894	854	485	791
Cash & Short-Term Investments	27	52	31	45	43	42	33	38	69	49	47	129	92	83	110	92	174	238	255	275	203	236	337	439	616	763	894	854	485	791
Receivables	69	60	64	75	61	62	67	115	75	111	111	136	129	139	126	147	175	186	179	181	201	253	288	319	385	489	507	512	553	574
Inventory	44	38	44	42	41	34	41	48	57	61	98	112	116	129	147	152	162	177	182	181	199	215	215	236	321	378	415	435	377	444
Property, Plant & Equipment	–	–	–	–	236	210	223	256	284	328	385	482	531	577	555	594	669	712	706	721	778	855	822	839	943	1,058	1,158	1,513	1,716	1,843
Goodwill	–	–	–	–	52	33	36	42	42	90	103	109	105	114	113	112	113	114	109	105	103	108	106	108	111	110	107	109	106	110
Intangible Assets	59	52	61	67	52	33	45	48	44	70	66	55	50	56	55	52	51	48	42	38	23	22	20	30	31	23	18	15	11	7.7
Total Liabilities	225	200	277	320	343	335	328	366	348	490	499	695	682	692	669	744	835	765	713	671	599	197	583	768	939	978	932	949	961	1,094
Current Liabilities	66	58	104	104	79	75	88	119	117	125	157	183	159	171	170	243	262	237	253	314	241	280	284	342	503	594	519	672	550	655
Short-Term Debt	2.9	1.6	36	30	3.6	8.7	16	8.0	10	0.3	0.5	0.5	3.9	0.5	0.3	50	33	2.2	27	69	2.4	103	0.1	12	12	54	18	152	19	23
Accounts Payable	24	19	21	26	24	23	19	29	29	46	61	80	68	68	63	90	103	108	103	120	122	138	130	157	213	232	215	242	239	254
Long-Term Debt	–	–	–	–	196	184	159	167	151	281	236	395	382	379	358	299	379	371	310	229	226	197	196	255	253	209	207	73	203	203
Shareholders' Equity	252	278	230	231	205	177	202	258	301	334	415	485	487	579	626	655	729	906	957	1,024	1,118	1,666	1,396	1,573	1,855	2,335	2,685	2,881	2,682	3,176
Retained Earnings	218	253	249	278	270	254	261	281	288	319	376	450	517	569	613	665	720	805	902	965	1,072	1,178	1,353	1,549	1,847	2,457	2,988	3,523	3,957	4,375
Shares Outstanding	66	66	66	60	58	57	58	58	62	65	67	72	72	73	73	74	72	71	73	74	75	76	75	75	76	76	76	75	74	73

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings